Predictive factors of lack of response to adalimumab among bio-naive patients suffering from moderate-to severe psoriasis: analysis of a multicenter data collection in Italy.
Arianna ZangrilliGiacomo CaldarolaNicoletta BernardiniMauro BavettaDario GraceffaClaudio BonifatiFranca CantoresiSara FaleriDomenico GiordanoMarco MarianiAdriana MicheliGaia MorettaFederico PirroGianluca PagnanelliVincenzo PanasitiAlessia ProviniAntonio Giovanni RichettaLidia SacchelliLuca BianchiKetty PerisPublished in: Expert opinion on biological therapy (2021)
This real-life analysis might be useful for clinicians in case of bio-naive patients with moderate-to-severe psoriasis and various comorbidities.
Keyphrases
- end stage renal disease
- ejection fraction
- hiv infected
- chronic kidney disease
- newly diagnosed
- early onset
- high intensity
- prognostic factors
- peritoneal dialysis
- palliative care
- clinical trial
- electronic health record
- patient reported outcomes
- cross sectional
- drug induced
- atopic dermatitis
- juvenile idiopathic arthritis